Welcome to our dedicated page for ALBEMARLE SEC filings (Ticker: ALB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Albemarle Corporation filings document operating results, material events, governance matters, shareholder voting items, and capital-structure disclosures for a public specialty chemicals and critical materials company. Form 8-K reports cover quarterly financial results, credit agreement amendments, debt-related actions, board appointments, officer transitions, and completed portfolio transactions.
Proxy materials describe director elections, committee governance, executive compensation, shareholder proposals, and voting procedures. Albemarle's filing record also documents the completed disposition of a controlling stake in Ketjen, retained ownership interests, integration of Performance Catalyst Solutions, and financing arrangements tied to the company's global lithium, bromine and specialty product businesses.
LaBauve Donald J. Jr. reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation executive Donald J. LaBauve Jr., VP, Corporate Controller & CAO, received an award of 698 shares of Common Stock on a grant/award basis at $0.00 per share. Following this award, his directly held Common Stock totaled 10,402 shares.
A related footnote explains that these are restricted stock units that vest 100% on March 2, 2029, subject to the award agreement. He also reported 12,755 shares of Common Stock held indirectly through the Albemarle Corporation Retirement Savings Plan.
Krupa Ander C. reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corp reported that its General Counsel & Secretary, Ander C. Krupa, was granted 1,796 restricted stock units on March 2, 2026. According to the award terms, these restricted stock units vest 100% on March 2, 2029, increasing the officer’s directly held common stock-related interest to 13,184 shares after the award.
Mummert Mark Richard reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corp’s Chief Supply Chain Officer, Mark Richard Mummert, received an equity award of 3,143 shares of common stock on 03/02/2026. The award is in the form of Restricted Stock Units that vest 100% on 03/02/2029, subject to the terms of the award agreement. Following this grant, his directly owned common stock holdings total 17,515 shares.
Albemarle Corporation’s Chairman and CEO J Kent Masters reported an equity award. He acquired 22,450 shares in the form of restricted stock units granted at no cash cost, which vest 100% on 03/30/2027. Following this grant, he beneficially owns 146,411 common shares directly.
Anderson Melissa H. reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation executive Melissa H. Anderson, Chief Business Transformation Officer, received a grant of 4,490 shares of common stock on March 2, 2026, at no cost as a stock award. These restricted stock units vest 100% on June 30, 2027, under the award agreement. Following the grant, she directly holds 14,002 shares of common stock and indirectly holds 179.1617 shares through the Albemarle Savings Plan.
Gagarinas Autumn M. reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corp’s Chief People Officer, Autumn M. Gagarinas, reported an equity award on a Form 4. She received 1,796 shares of common stock in the form of Restricted Stock Units at a stated price of $0.00 per share, bringing her direct holdings to 5,393 shares. The RSUs vest 100% on 03/02/2029, subject to the terms of the award agreement.
Albemarle Corporation reported that senior vice president Cynthia Renee Lima received an equity award of 1,796 shares of common stock as a grant or other acquisition. The award was priced at $0.00 per share, increasing her directly held stake to 14,438 shares. According to the terms, these restricted stock units vest 100% on March 2, 2029, tying a portion of her compensation to the company’s long-term performance.
Albemarle Corporation filed an update describing changes to its Board of Directors. Effective February 26, 2026, the Board appointed Michelle T. Collins and Mark R. Widmar as independent directors. Collins joined the Audit & Finance and Governance & Public Policy Committees, while Widmar joined the Executive Compensation & Talent Development and Safety, Sustainability, Operations & Capital Committees.
Under Albemarle’s non-employee director compensation program, each new director will receive an annual cash retainer of $120,000, paid quarterly and prorated for their partial initial term, plus an annual grant of restricted stock valued at $170,000, rounded to the nearest 25 shares and prorated for the partial year. The company states there are no special arrangements behind their selection and no related-party transactions requiring disclosure. A press release dated March 2, 2026, further announcing these appointments is furnished as an exhibit.
Albemarle Corporation’s Chief Commercial Officer Eric Norris reported equity compensation activity involving company common stock. He acquired 1,806 shares on February 26, 2026 at $184.93 per share through the vesting of previously granted Performance Stock Units, bringing his direct holdings to 49,738 shares.
On the same date, 785 shares at $184.93 per share were disposed of to cover tax liabilities tied to the 2023 Performance Stock Unit grant vesting. After this tax-withholding disposition, Norris held 48,953 shares of Albemarle common stock directly.
Albemarle Corp executive Mark Richard Mummert reported equity award activity involving company common stock. On February 26, 2026, he acquired 366 shares at $184.93 per share through a grant/award tied to Performance Stock Units originally granted on February 24, 2023. The footnotes explain that these units were split between ROIC and rTSR Performance Stock Units and that all shares earned vested on February 26, 2026. On the same date, 159 shares at $184.93 per share were disposed of to cover tax liabilities associated with this vesting. Following these transactions, he held 14,372 shares of Albemarle common stock directly.